UNSPSC 85874112: Magnetic resonance imaging (mri) of superior vena cava using other contrast, unenhanced and enhanced

This classification denotes the group of activities that yields a imaging intervention or procedure to magnetic resonance imaging (mri) of superior vena cava using other contrast, unenhanced and enhancedmagnetic resonance imaging (mri) of superior vena cava using other contrast, unenhanced and enhanced. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code B538Y0Z

UNSPSC 85874112 Magnetic resonance imaging (MRI) of superior vena cava using other contrast, unenhanced and enhanced is a Commodity code that shows little relevant recent activity. The three most recent state and local opportunities tagged to this code—a diagnostic imaging PACS system procurement from San Mateo Medical Center, special education contracted services from Birdville Independent School District, and a temporary health professional staffing qualification vehicle from Santa Clara Health System—are plainly unrelated to the narrow clinical imaging scope the code nominally describes. The San Mateo opportunity involves enterprise PACS software implementation, data migration, and system integration rather than a discrete imaging service or procedure. The Birdville and Santa Clara opportunities concern educational and clinical staffing services with no connection to MRI imaging at all. The mismatch suggests either inconsistent coding practices at the issuing bodies or upstream data quality issues in the opportunity feed.

State and local procurement bodies do purchase diagnostic imaging services, but the opportunities in this sample do not align with the specific MRI protocol named in the code. Business development professionals evaluating this code should verify whether the code is actually used for imaging service procurements at their target jurisdictions, and if so, request recent bid documents and awarded contracts directly from those buyers to establish genuine market patterns and issuing-body concentration. The code as currently populated offers no actionable intelligence for competitive positioning.